WO2009057763A1 - 新規アジュバント - Google Patents
新規アジュバント Download PDFInfo
- Publication number
- WO2009057763A1 WO2009057763A1 PCT/JP2008/069919 JP2008069919W WO2009057763A1 WO 2009057763 A1 WO2009057763 A1 WO 2009057763A1 JP 2008069919 W JP2008069919 W JP 2008069919W WO 2009057763 A1 WO2009057763 A1 WO 2009057763A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine
- infection
- allergen
- mucosal
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
アレルゲンワクチン、感染症ワクチン、粘膜ワクチン又は腫瘍ワクチンと併用するワクチンアジュバント組成物の提供。ヘモゾイン又はβヘマチンを含むアレルゲンワクチン、感染症ワクチン、粘膜ワクチン又は腫瘍ワクチンと併用するアジュバント組成物並びに該アジュバント組成物並びにアレルゲンワクチン、感染症ワクチン、粘膜ワクチン若しくは腫瘍ワクチンを含むワクチン組成物。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/740,899 US9056094B2 (en) | 2007-11-02 | 2008-10-31 | Adjuvant |
JP2009539133A JP5292303B2 (ja) | 2007-11-02 | 2008-10-31 | 新規アジュバント |
EP08845024.2A EP2221062B1 (en) | 2007-11-02 | 2008-10-31 | Novel adjuvant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007285737 | 2007-11-02 | ||
JP2007-285737 | 2007-11-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009057763A1 true WO2009057763A1 (ja) | 2009-05-07 |
Family
ID=40591143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/069919 WO2009057763A1 (ja) | 2007-11-02 | 2008-10-31 | 新規アジュバント |
Country Status (4)
Country | Link |
---|---|
US (1) | US9056094B2 (ja) |
EP (1) | EP2221062B1 (ja) |
JP (1) | JP5292303B2 (ja) |
WO (1) | WO2009057763A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011074711A1 (ja) | 2009-12-18 | 2011-06-23 | 国立大学法人大阪大学 | βヘマチンを含むアジュバント |
US8894996B2 (en) | 2009-02-27 | 2014-11-25 | Osaka University | Immunoadjuvant composition and use thereof |
WO2014196657A1 (ja) | 2013-06-04 | 2014-12-11 | 国立大学法人大阪大学 | 加熱工程を含むβヘマチン結晶の製造方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005231004B2 (en) | 2004-04-09 | 2011-06-02 | Nippon Zenyaku Kogyo Co., Ltd. | Novel mite allergen |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849307A (en) | 1997-03-26 | 1998-12-15 | The Picower Institute For Medical Research | Vaccine adjuvant |
WO2006061965A1 (ja) | 2004-12-09 | 2006-06-15 | Osaka University | ヘモゾイン誘導による自然免疫を利用したマラリア感染症の検出・測定、マラリア感染症の予防又は治療薬のスクリーニング、及び該自然免疫誘導の調節 |
WO2007147255A1 (en) * | 2006-06-22 | 2007-12-27 | Mcgill University | Synthetic monodisperse hemozoin crystals preparation and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19601754A1 (de) * | 1996-01-19 | 1997-07-24 | Hoechst Ag | Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung |
US5846735A (en) * | 1996-04-18 | 1998-12-08 | University Of Iowa Research Foundation | Hepatitis C virus Fc-binding function |
EP0948625B1 (en) * | 1996-12-20 | 2011-01-26 | The Board Of Regents, The University Of Texas System | Uspa1 and uspa2 antigens of moraxella catarrhalis |
-
2008
- 2008-10-31 US US12/740,899 patent/US9056094B2/en active Active
- 2008-10-31 JP JP2009539133A patent/JP5292303B2/ja active Active
- 2008-10-31 WO PCT/JP2008/069919 patent/WO2009057763A1/ja active Application Filing
- 2008-10-31 EP EP08845024.2A patent/EP2221062B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849307A (en) | 1997-03-26 | 1998-12-15 | The Picower Institute For Medical Research | Vaccine adjuvant |
WO2006061965A1 (ja) | 2004-12-09 | 2006-06-15 | Osaka University | ヘモゾイン誘導による自然免疫を利用したマラリア感染症の検出・測定、マラリア感染症の予防又は治療薬のスクリーニング、及び該自然免疫誘導の調節 |
WO2007147255A1 (en) * | 2006-06-22 | 2007-12-27 | Mcgill University | Synthetic monodisperse hemozoin crystals preparation and uses thereof |
Non-Patent Citations (9)
Title |
---|
INFECT. IMMUN., vol. 70, 2002, pages 3939 - 3943 |
INFECT. IMMUN., vol. 70, no. 7, July 2002 (2002-07-01), pages 3939 - 43 |
J EXP MED., vol. 201, no. 1, 3 January 2005 (2005-01-03), pages 19 - 25 |
J. IMMUNOL., vol. 172, pages 3101 - 3110 |
PROC. NATL. ACAD. SCI. U.S.A., vol. 88, 1991, pages 325 - 329 |
PROC. NATL. ACAD. SCI. U.S.A., vol. 88, pages 325 - 329 |
PROC. NATL. ACAD. SCI. U.S.A., vol. 93, 1996, pages 11865 - 11870 |
See also references of EP2221062A4 * |
SLATER ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 88, 1991, pages 325 - 329 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8894996B2 (en) | 2009-02-27 | 2014-11-25 | Osaka University | Immunoadjuvant composition and use thereof |
WO2011074711A1 (ja) | 2009-12-18 | 2011-06-23 | 国立大学法人大阪大学 | βヘマチンを含むアジュバント |
JP5832904B2 (ja) * | 2009-12-18 | 2015-12-16 | 国立大学法人大阪大学 | βヘマチンを含むアジュバント |
WO2014196657A1 (ja) | 2013-06-04 | 2014-12-11 | 国立大学法人大阪大学 | 加熱工程を含むβヘマチン結晶の製造方法 |
US9732107B2 (en) | 2013-06-04 | 2017-08-15 | Osaka University | Method for producing beta-hematin crystal comprising step of heating |
Also Published As
Publication number | Publication date |
---|---|
US9056094B2 (en) | 2015-06-16 |
EP2221062B1 (en) | 2014-05-21 |
JPWO2009057763A1 (ja) | 2011-03-10 |
EP2221062A1 (en) | 2010-08-25 |
US20100247568A1 (en) | 2010-09-30 |
EP2221062A4 (en) | 2011-02-09 |
JP5292303B2 (ja) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI340161B (en) | Acrylic pressure-sensitive adhesive composition with good re-workability,adhesive sheet,and method of preparing the sheet | |
WO2009120893A3 (en) | Polypeptide-polymer conjugates and methods of use thereof | |
WO2008021156A3 (en) | Antibodies to il-17a | |
WO2009098691A8 (en) | Audio and video embedded bedding | |
WO2007131101A3 (en) | Adapter to convert usb device into wireless usb device | |
EP1872793A4 (en) | POLYAMINO ACID FOR USE AS ADJUVANS | |
IL193397A0 (en) | Hpv antigens, vaccine compositions, and related methods | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
ZA201008348B (en) | Alcohol alkoxylates, agents comprising the same and use of the alcohol alkoxylates as adjuvants in the agrochemical field. | |
WO2011138040A8 (en) | Vaccine against beta-herpesvirus infection and use thereof | |
WO2007057018A3 (en) | Glucoamylase variants | |
WO2010118866A8 (en) | Trehalulose-containing composition, its preparation and use | |
WO2008017079A3 (en) | Dyes and precursors and conjugates thereof | |
MY161755A (en) | Soy adhesives and composites made from the adhesives | |
EP2305771A4 (en) | PHOSPHORESCENCE-EMITTING COMPOSITION, AND LIGHT-EMITTING ELEMENT USING THE SAME | |
EP2245113A4 (en) | PHOSPHORESCENT COMPOSITIONS, METHODS FOR PREPARING THE COMPOSITIONS, AND METHODS OF USING THE COMPOSITIONS | |
WO2012061599A3 (en) | Vaccines against toxoplasma gondii | |
GB0615635D0 (en) | Immunogenic proteins and uses thereof | |
ZA201004337B (en) | Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing the same | |
WO2009057763A1 (ja) | 新規アジュバント | |
WO2007034166A8 (en) | Adjuvanted vaccine | |
USD609972S1 (en) | Covered wine glass | |
EP2076544A4 (en) | ANTI-OBESITY IMMONOGENIC HYBRID POLYPEPTIDES AND ANTI-OBESITY VACCINE COMPOSITION COMPRISING THE SAME | |
MX2013004074A (es) | Dispositivo de succion. | |
WO2005086637A3 (en) | Anthrax antigens and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08845024 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009539133 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12740899 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008845024 Country of ref document: EP |